Home Forums *News Top Industry News December 18 – 22

Top Industry News December 18 – 22

Home Forums *News Top Industry News December 18 – 22

    • Lauren Feldman

      Forbes (December 22, 2023) MicroMachines: Advances In Biorobotic Regenerative Medicine

      Anthrobots, or biobots, as described by Dr. Gizen Gumuskaya and colleagues from Tufts University in a recent study, are spherical multicellular robots derived from our own human lung cells. The biobots range in diameter from only 30 to 500 micrometers. For context, the edge of a penny is over 1500 micrometers. Gumuskaya and colleagues found that the autonomous robots could self-organized repair of tissue damage, in essence, patching up a scratch without human direction. This capability could open the door to a range of future applications.


      Inside Precision Medicine (December 20, 2023) Revolutionizing Healthcare: Innovations in Regenerative Medicine Offer Hope

      From cell therapies to gene editing to biomechanical interventions, regenerative medicine holds promise in transforming healthcare as we know it. Just as the seasons bring forth new beginnings, regenerative medicine ushers in a new era of hope for those who need healing.


      News Medical (December 18, 2023) “Forever chemicals” could contribute to cancer metastasis in living organisms

      In a new study by researchers at the Yale School of Public Health, two “forever chemicals” spurred cancer cells in the lab to migrate to new positions, an indication that the chemicals could contribute to cancer metastasis in living organisms. The study addressed the group of industrial chemicals called per- and polyfluoroalkyl substances (PFAS). The substances are known as “forever chemicals” because they don’t break down in the environment and can build up in the human body. They have the ability to shed water and resist penetration by oils. They are notorious for their ubiquity, their exceptional environmental stability, and their suspected toxic effects.


      Medical Xpress (December 17, 2023) Exploring the effects of vascularization strategies on brain organoids

      Cerebral organoids are three-dimensional, in vitro cultured brains that mimic the activities of the human brain. They have emerged as invaluable tools to comprehend evolution, disease pathogenesis, and neurodevelopmental processes. However, the development of these organoids is still in the nascent stages, with several limitations that hinder their broad applications. A major obstacle is the absence of a functional vasculature that can restrict the size of organoids, trigger cell death, and prevent cell differentiation in the organoids. To address this, diverse strategies aiming to vascularize human cerebral organoids have been developed.

Viewing 0 reply threads
  • You must be logged in to reply to this topic.